HighTower Advisors »

Brainstorm Cell Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0k 10k 0.29
2023-09-30 $2.0k 11k 0.19
2021-03-31 $40k 11k 3.80
2019-09-30 $40k 10k 3.90
2019-06-30 $41k 10k 3.99
2019-03-31 $46k 11k 4.27
2018-12-31 $39k 11k 3.62
2018-09-30 $41k 11k 3.81
2018-06-30 $42k 11k 3.90
2018-03-31 $35k 11k 3.25
2017-12-31 $42k 11k 3.90
2017-09-30 $42k 10k 4.09
2017-06-30 $43k 10k 4.19
2017-03-31 $46k 11k 4.27
2016-12-31 $27k 11k 2.51
2016-09-30 $26k 11k 2.42
2016-06-30 $26k 11k 2.42
2016-03-31 $29k 11k 2.69
2015-03-31 $54k 12k 4.40
2014-12-31 $49k 10k 4.77